BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
BioCardia (NASDAQ: BCDA), a leader in cardiovascular and pulmonary disease therapeutics, has announced a correction to their conference call timing for discussing two-year CardiAMP-HF results. The call is scheduled for March 31, 2025, at 4:30 PM EDT, not PDT as previously stated.
U.S. participants can call 1-833-316-0559, while international callers should dial 1-412-317-5730. Pre-registration is available at dpregister.com/sreg/10194429/fdf5f0e427. A live webcast will be accessible through event.choruscall.com, with replay options available approximately one hour after the call concludes.
BioCardia (NASDAQ: BCDA), un leader nelle terapie per le malattie cardiovascolari e polmonari, ha annunciato una correzione riguardo l'orario della loro conferenza telefonica per discutere i risultati di CardiAMP-HF dopo due anni. La chiamata è programmata per 31 marzo 2025, alle 16:30 EDT, e non PDT come precedentemente dichiarato.
I partecipanti statunitensi possono chiamare il 1-833-316-0559, mentre i chiamanti internazionali dovrebbero comporre il 1-412-317-5730. È disponibile la pre-registrazione su dpregister.com/sreg/10194429/fdf5f0e427. Una diretta streaming sarà accessibile tramite event.choruscall.com, con opzioni di replay disponibili circa un'ora dopo la conclusione della chiamata.
BioCardia (NASDAQ: BCDA), un líder en terapias para enfermedades cardiovasculares y pulmonares, ha anunciado una corrección sobre el horario de su llamada de conferencia para discutir los resultados de CardiAMP-HF a dos años. La llamada está programada para 31 de marzo de 2025, a las 4:30 PM EDT, y no PDT como se había indicado anteriormente.
Los participantes de EE. UU. pueden llamar al 1-833-316-0559, mientras que los llamadores internacionales deben marcar el 1-412-317-5730. La preinscripción está disponible en dpregister.com/sreg/10194429/fdf5f0e427. Una transmisión en vivo estará accesible a través de event.choruscall.com, con opciones de repetición disponibles aproximadamente una hora después de que concluya la llamada.
BioCardia (NASDAQ: BCDA), 심혈관 및 호흡기 질환 치료의 선두주자인 BioCardia가 CardiAMP-HF 2년 결과에 대한 컨퍼런스 콜 일정 수정을 발표했습니다. 이 콜은 2025년 3월 31일 오후 4시 30분 EDT로 예정되어 있으며, 이전에 언급된 PDT가 아닙니다.
미국 참가자는 1-833-316-0559로 전화할 수 있으며, 국제 발신자는 1-412-317-5730으로 전화해야 합니다. 사전 등록은 dpregister.com/sreg/10194429/fdf5f0e427에서 가능합니다. 라이브 웹캐스트는 event.choruscall.com을 통해 접근할 수 있으며, 콜이 종료된 후 약 한 시간 후에 재생 옵션이 제공됩니다.
BioCardia (NASDAQ: BCDA), un leader dans les thérapies pour les maladies cardiovasculaires et pulmonaires, a annoncé une correction concernant l'heure de leur conférence téléphonique pour discuter des résultats de CardiAMP-HF après deux ans. L'appel est prévu pour le 31 mars 2025, à 16h30 EDT, et non PDT comme indiqué précédemment.
Les participants américains peuvent appeler le 1-833-316-0559, tandis que les appelants internationaux doivent composer le 1-412-317-5730. Une pré-inscription est disponible sur dpregister.com/sreg/10194429/fdf5f0e427. Un webinaire en direct sera accessible via event.choruscall.com, avec des options de rediffusion disponibles environ une heure après la fin de l'appel.
BioCardia (NASDAQ: BCDA), ein führendes Unternehmen in der Therapie von Herz-Kreislauf- und Lungenerkrankungen, hat eine Korrektur bezüglich des Zeitplans ihrer Telefonkonferenz zur Diskussion der zweijährigen Ergebnisse von CardiAMP-HF angekündigt. Der Anruf ist für 31. März 2025, um 16:30 Uhr EDT angesetzt, nicht PDT wie zuvor angegeben.
Teilnehmer aus den USA können 1-833-316-0559 anrufen, während internationale Anrufer 1-412-317-5730 wählen sollten. Eine Voranmeldung ist unter dpregister.com/sreg/10194429/fdf5f0e427 möglich. Ein Live-Webcast wird über event.choruscall.com zugänglich sein, mit Wiedergabeoptionen, die etwa eine Stunde nach dem Ende des Anrufs verfügbar sind.
- None.
- None.
SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today clarifies that two-year CardiAMP-HF results will be addressed in a conference call scheduled for today, Monday, March 31, 2025 at 4:30pm EDT. The press release earlier this morning incorrectly noted the call would be held at 4:30pm PDT.
To access the call today:
Participants can register for the conference by navigating to https://dpregister.com/sreg/10194429/fdf5f0e427. Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730 and ask to be connected to the BioCardia call. All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the BioCardia call. The conference call will also be available through a live webcast, which can be accessed through the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=fyO2WNaO.
A webcast replay of the call will be available approximately one hour after the end of the call at the above links. To access the replay internationally, please use the link https://services.choruscall.com/ccforms/replay.html. A telephonic replay of the call will be available and may be accessed by calling 1-877-344-7529 (domestic), 1-412-317-0088 (international) or 855-669-9658 (Canada) by using access code 6220156.
Media Contact: Miranda Peto, Marketing / Investor Relations Email: mpeto@BioCardia.com Phone: 650-226-0120 Investor Contact: David McClung, Chief Financial Officer Email: investors@BioCardia.com Phone: 650-226-0120
FAQ
When is BioCardia's (BCDA) conference call for CardiAMP-HF results?
How can investors join BioCardia's (BCDA) March 31 conference call?
What will be discussed in BioCardia's (BCDA) March 2025 conference call?
How can investors access the replay of BioCardia's (BCDA) March 31 conference call?
